Director/Sr. Director, Business Development
$200k/y-$300k/y
BigHat Biosciences18 hours ago
Highlight
OnsiteFull-timeSenior
Summary
BigHat Biosciences is seeking a Director/Sr. Director, Business Development to join their team in San Mateo, CA. The role focuses on driving corporate development and partnering to position BigHat as a partner of choice in the biotechnology sector.
About the Role
As a Director/Sr. Director of Business Development, you will execute business development strategies aligned with corporate objectives, assess the AI protein therapeutic landscape, develop materials to communicate BigHat's value proposition, and build relationships with prospective partners. You will also advance discussions to collaboration and licensing agreements, increase awareness of the BigHat Milliner platform, and perform market analyses for potential pipeline programs.
About You
Required:
- Minimum of 5-10 years of experience in biopharma business development, corporate development, or strategy.
- Bachelor of Science; MBA or consulting, PhD, or MD preferred.
- Strong and effective communication skills, both verbal and written.
- Proven analytical skills and business acumen.
Preferred:
- Proactive, self-starter, collaborative, ambitious BD professional.
- Experience in biotech partnering.
- Understanding of contracts and negotiation tactics.
- Financial and budgetary experience.
Benefits
- Competitive salary range of $200k–$300k, commensurate with skill set and experience.
- Opportunities for professional growth and development.
BigHat Biosciences
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.
San Mateo, CA